Developmental abnormalities in the nerves of peripheral myelin protein 22-deficient mice

✍ Scribed by Stephanie A. Amici; William A. Dunn Jr.; Lucia Notterpek

• Publisher: John Wiley and Sons
• Year: 2007
• Tongue: English
• Weight: 698 KB
• Volume: 85
• Category: Article
• ISSN: 0360-4012
• DOI: 10.1002/jnr.21118

✦ Synopsis

Abstract

Peripheral myelin protein 22 (PMP22) is a tetraspan glycoprotein whose misexpression is associated with a family of hereditary peripheral neuropathies. In a recent report, we have characterized a novel PMP22‐deficient mouse model in which the first two coding exons were replaced by the lacZ reporter. To investigate further the myelin abnormalities in the absence of PMP22, sciatic nerves and dorsal root ganglion (DRG) neuron explant cultures from PMP22‐deficient mice were studied at various stages of myelination. Throughout the first 3 months of postnatal development, myelin protein and β4 integrin levels are dramatically reduced, whereas p75 and β1 integrin remain elevated. By immunostaining, the distributions of several glial proteins, including β4 integrin, the voltage‐gated potassium channel Kv1.1, and E‐cadherin, are altered. Schwann cells from PMP22‐deficient mice are able to produce limited amounts of myelin in DRG explant cultures, yet the internodal segments are dramatically fewer and shorter. The comparison of PMP22‐deficient mice with other PMP22 mutant models reveals that the decrease in β4 integrin is specific to an absence of PMP22. Furthermore, whereas lysosome‐associated membrane protein 1 and ubiquitin are notably up‐regulated in nerves of PMP22‐deficient mice, heat shock protein 70 levels remain constant or decrease compared with wild‐type or PMP22 mutant samples. Together these results support a role for PMP22 in the early events of peripheral nerve myelination. Additionally, although myelin abnormalities are a commonality among PMP22 neuropathic models, the underlying subcellular mechanisms are distinct and depend on the specific genetic abnormality. © 2006 Wiley‐Liss, Inc.